Phil Johnson calls for fairness in PTAB proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Phil Johnson calls for fairness in PTAB proceedings

ptab-web-icon.jpg

In a session at the AIPLA Annual Meeting, David Kappos said that Federal Circuit decisions will show whether the Patent and Trial Appeal Board (PTAB) is on the right track while Phil Johnson stressed that the proceedings must be perceived as fair

Kappos, partner at Cravath Swaine & Moore, and former director of the USPTO, praised the job the PTAB has done in keeping up with its higher-than-expected workload. He said it was too early to assess how the Board is doing in its ­decisions.

“One thing I would say is that the ultimate arbiter of whether the PTAB is getting these things right is going to be the Federal Circuit and, to some extent, the Supreme Court," Kappos said, “We need to reserve judgment and look to the court decisions and also look to the basis of the court decisions. I would see it as OK if the agency gets reversed on close calls, judgment calls on things like 103 decisions. I certainly ­wouldn’t see it as OK if you start getting into ­arbitrary and capricious or abuse of ­discretion kinds of things, though I see no indication that is a problem yet.”

The USPTO asked for feedback on PTAB proceedings and received 37 comments by its deadline last week. Quite a few of the comments raised concerns about the constraints under the proceedings, such as the lack of ability to amend. Many believe the proceedings are weighted too much in petitioners’ favor and are unfair to patent owners.

“What is really at stake here is: how fair are these proceedings going to be perceived as?” Johnson , senior vice-president for intellectual property at Johnson & Johnson, said. “Ultimately if they are perceived as being unfair there will be reactions, whether the reaction is from the Federal Circuit or whether the reaction is from Congress, or whether the reaction is from businesses who say, ‘If every important patent I get can easily be invalidated by taking it into IPR, why should I be doing anything in the patent system? Why shouldn’t I be doing trade secrets or whatever my other alternatives are?

“We all have a strong interest in making sure these proceedings are not only fair but also that they are perceived to be fair. If it may make a difference in perception on the side of fairness, that is something worth going for. These are extremely important issues and I am really glad the PTO has taken the step to go out and get comments. Frankly, if it gets messed up we could lose even more credibility with the patent system itself and that to me is a big long-term risk.”

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article